Krista Qualmann on Genetic Counseling and Testing for Patients with Cancer

Video

Krista Qualmann discusses hereditary cancer syndromes.

Krista Qualmann, MS, CGC, Memorial Hermann Mischer Neuroscience Institute at the Texas Medical Center and UTHealth, discusses hereditary cancer syndromes.

About 5% to 10% of cancers are caused by single-gene disorders. These hereditary cancer syndromes are most well-known for causing cancers such as breast cancer, ovarian cancer and endometrial cancer. They can also have a hand in colon cancer, brain tumors and melanoma.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with dark curly hair wearing a floral shirt
3 experts in this video
3 experts in this video
Image of a woman with gray hair on a light blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a private infusion bay with a large screen for video calls
2 experts are featured in this series.
Related Content
Amanda Brink discusses AI-driven image analysis in HER2 scoring in breast cancer.

Opinion: Artificial Intelligence Enhances Precision in HER2 Scoring for Breast Cancer

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
May 19th 2025
Article

Oncology nurses can help advocate for AI-assisted diagnostic improvements.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Anatomical aerial image of a person with a brain tumor

Phase 2B Glioblastoma Vaccine Trial Cleared to Continue

Russ Conroy
May 14th 2025
Article

The phase 2b SURVIVE trial of SurVaxM in newly diagnosed glioblastoma will continue as planned following an interim review by an independent safety board.

The Vitals

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials

Lindsay Fischer
July 15th 2023
Podcast

Jacki Garcia, RN, BSN, CNRN; and Kristin Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.

Graphic depicting the female reproductive system with cancer cells surrounding

Adavosertib Yields Preliminary Safety Concerns, Antitumor Activity in USC

Ashley Chan
May 12th 2025
Article

Treatment-related adverse effects were reported in 97.2% of heavily pretreated patients with uterine serous carcinoma taking adavosertib.

Illustration of a brain with a magnifying glass showing a tumor. Behind the brain is a medical chart.

NCCN Guidelines Now Recommend Naxitamab for High-Risk Neuroblastoma

Jax DiEugenio
May 9th 2025
Article

An update to the NCCN guidelines recommends naxitamab-gqgk for adult and pediatric patients with high-risk neuroblastoma.